Home LiteratureArticle Details
PMID: 1732413 Published · ppublish English Journal Article

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.

The Journal of experimental medicine ·Vol. 175 ·No. 2 ·1992-02-01 ·Pages 481-7

Eisenlohr LC, Yewdell JW, Bennink JR

Abstract

Cytotoxic T lymphocytes (CTL) recognize class I major histocompatibility complex molecules complexed to peptides of eight to nine residues generated from cytosolic proteins. We find that CTL recognize, in vitro and in vivo, cells synthesizing a 10-residue peptide consisting of an initiating methionine followed by nine residues corresponding to a naturally processed determinant from influenza virus nucleoprotein (NP) (residues 147-155). Addition of two COOH-terminal residues corresponding to NP residues 157 and 158 severely reduced presentation of the endogenously produced peptide to CTL in vitro and in vivo. Extension of NH2 and COOH terminal flanking residues to include residues corresponding to NP residues 137-146 and 159-168 failed to increase the antigenicity of this peptide. Its presentation was greatly enhanced, however, by further extending the NH2 and COOH termini to include all of the additional residues of NP. These findings indicate first, that a naturally processed viral ligand (with an NH2-terminal Met) of a class I molecule contains sufficient information to access intracellular class I molecules, and second, that flanking residues can influence the processing and presentation of antigens to CTL.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Blotting, Northern Cytotoxicity Tests, Immunologic Genes, Viral Histocompatibility Antigens Class I/immunology Influenza A virus/genetics,immunology Ligands Mice Mice, Inbred BALB C Molecular Sequence Data Nucleocapsid Proteins Nucleoproteins/genetics,immunology Oligopeptides/chemical synthesis,genetics,immunology Polymerase Chain Reaction RNA-Binding Proteins T-Lymphocytes, Cytotoxic/immunology Viral Core Proteins/genetics,immunology Viral Structural Proteins/genetics
Chemicals
Histocompatibility Antigens Class I Ligands NP protein, Influenza A virus Nucleocapsid Proteins Nucleoproteins Oligopeptides RNA-Binding Proteins Viral Core Proteins Viral Structural Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Eisenlohr L C
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Yewdell J W
Bennink J R
References (35)
35 references, click to expand
  1. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes.
    J Exp Med. 1989 Sep 1;170(3):1033-8 PMID: 2475568
  2. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation.
    Nature. 1989 May 18;339(6221):223-6 PMID: 2785645
  3. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
    J Exp Med. 1989 Mar 1;169(3):603-12 PMID: 2784478
  4. Cytotoxic T cells recognize fragments of the influenza nucleoprotein.
    Cell. 1985 Sep;42(2):457-67 PMID: 2411422
  5. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.
    Nature. 1989 Nov 9;342(6246):180-2 PMID: 2478887
  6. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes.
    J Exp Med. 1989 Sep 1;170(3):1051-6 PMID: 2475569
  7. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Eur J Immunol. 1986 Dec;16(12):1479-87 PMID: 3493144
  8. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein.
    Cell. 1988 Jan 29;52(2):253-8 PMID: 2449284
  9. Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.
    J Virol. 1986 Mar;57(3):786-91 PMID: 3485199
  10. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.
    J Immunol. 1989 Feb 15;142(4):1079-83 PMID: 2492575
  11. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9 PMID: 3872457
  12. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen.
    J Exp Med. 1989 Jan 1;169(1):297-302 PMID: 2462610
  13. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Cell. 1986 Mar 28;44(6):959-68 PMID: 2420472
  14. Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen.
    Nature. 1989 Feb 16;337(6208):653-5 PMID: 2537466
  15. The scanning model for translation: an update.
    J Cell Biol. 1989 Feb;108(2):229-41 PMID: 2645293
  16. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
    Nature. 1989 Aug 10;340(6233):443-8 PMID: 2666863
  17. The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation.
    J Biol Chem. 1990 Nov 15;265(32):19638-43 PMID: 2174047
  18. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles.
    J Exp Med. 1988 Nov 1;168(5):1935-9 PMID: 3263469
  19. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
    Mol Cell Biol. 1985 Dec;5(12):3403-9 PMID: 3939316
  20. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Science. 1990 Feb 9;247(4943):715-8 PMID: 2137259
  21. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen.
    Virology. 1983 Jul 30;128(2):319-30 PMID: 6310860
  22. Disquisitions of Original Antigenic Sin. I. Evidence in man.
    J Exp Med. 1966 Sep 1;124(3):331-45 PMID: 5922742
  23. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.
    Nature. 1990 Nov 15;348(6298):213-6 PMID: 1700303
  24. Transport protein genes in the murine MHC: possible implications for antigen processing.
    Science. 1990 Dec 21;250(4988):1723-6 PMID: 2270487
  25. Peptide selection by MHC class I molecules.
    Nature. 1991 Apr 25;350(6320):703-6 PMID: 1708852
  26. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
    Nature. 1990 Nov 15;348(6298):252-4 PMID: 1700304
  27. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.
    Cell. 1991 Sep 20;66(6):1145-53 PMID: 1913805
  28. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product.
    J Exp Med. 1991 Sep 1;174(3):733-6 PMID: 1875170
  29. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters.
    Nature. 1990 Dec 20-27;348(6303):738-41 PMID: 1979660
  30. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.
    Nature. 1990 Dec 20-27;348(6303):744-7 PMID: 2259384
  31. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters.
    Nature. 1990 Dec 20-27;348(6303):741-4 PMID: 2259383
  32. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Nature. 1990 Nov 15;348(6298):248-51 PMID: 2234092
  33. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
    J Exp Med. 1988 Oct 1;168(4):1211-24 PMID: 2459295
  34. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Science. 1989 Jun 2;244(4908):1072-5 PMID: 2471266
  35. Antigen recognition by class I-restricted T lymphocytes.
    Annu Rev Immunol. 1989;7:601-24 PMID: 2469442
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1992-02-01
Pages
481-7
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2119116
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]